期刊: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2022; 8 (4)
Aims The aim of this study was to investigate the effects of Neuraminidase inhibitors (NI) on COVID-19 in a retrospective study. Methods and results T......
期刊: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2022; 8 (4)
Aims We conducted this study to explore the associations of weekend and weekday admission with the clinical events among heart failure (HF) patients w......
期刊: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2022; 8 (2)
Aims The beneficial effect of beta-blocker on heart failure with reduced ejection fraction is well established. However, its effect on the 1-year outc......
期刊: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2021; 7 (3)
Aims Ticagrelor has been shown to reduce the risk of pneumonia and improve lung function, but the findings across studies were inconsistent. The objec......
期刊: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2021; 7 (3)
Aims To investigate the effects of aspirin-omitted dual antithrombotic therapy (DAT) on myocardial infarction and stent thrombosis in non-valvular atr......
期刊: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2020; 6 (4)
Aims: A number of studies have attempted to demonstrate the benefits associated with personalized antiplatelet therapy guided by platelet function tes......
期刊: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2020; 6 (1)
Aims The aim of the present study was to establish the safety and efficacy profile of prasugrel and ticagrelor in real-life acute coronary syndrome (A......
期刊: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2017; 3 (2)
Aims To investigate the relationship between visit-to-visit blood pressure variability (BPV) and the progression of both carotid and coronary artery d......